| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10963471 | Vaccine | 2015 | 8 Pages |
Abstract
The introduction of PCV7 was associated with a 22% significant reductions in OM in children aged <10 year-olds with an additional 19% reductions after PCV13 introduction. These declines are equivalent to 592,000 and 15,700 fewer consultations and OM-related hospitalizations, respectively, in England and Wales every year. Although the continuing decline in OM rates in our study suggests that further reduction may continue to occur, it is important to monitor long-term trends in all pneumococcal diseases, including OM and pneumonia, because of increasing replacement of non-vaccine pneumococcal serotypes in carriage and disease.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Wallis C.Y. Lau, Macey Murray, Aisha El-Turki, Sonia Saxena, Shamez Ladhani, Paul Long, Mike Sharland, Ian C.K. Wong, Yingfen Hsia,